SciELO - Scientific Electronic Library Online

 
vol.21 issue5Knowledge in parents about the asthma suffered by their childrenEffectiveness of the AliviHo®-rheumatism in patients with arthrosis of the knee author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO

Share


MEDISAN

On-line version ISSN 1029-3019

Abstract

LEMUS RODRIGUEZ, Martha Zoe; CHONG QUESADA, Amaury  and  BOSCH ESCOBAR, Jorge. Chewable pill of soy phosphatidylcholine: from by-product to pharmaceutical product. MEDISAN [online]. 2017, vol.21, n.5, pp.556-563. ISSN 1029-3019.

The development of a chewable pill of soy phosphatidylcholilne was undertaken in "Oriente" Pharmaceutical Laboratory from Santiago de Cuba with registration ends and subsequent production, that was carried out during the biennium 2011-2013. Excipients of pharmaceutical quality, the analytic methods of the United States Pharmacopoeia, edition 35/National Form, 2012 30th edition, as well as the technology of humid granulation and direct compression were used. Phosphatidylcholine was characterized as pharmaceutical raw material and the developed pill fulfilled the established quality attributes, reason why it was registered with 2 years proven stability. Added value was given to this substance, with potential risk of accumulation for the environment, as new pharmaceutical product in Cuba

Keywords : phosphatidylcholine; chewable pill; soy; cholesterol; "Oriente" Pharmaceutical Laboratory.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License